Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. !NOW WITH ‘USA VIEW’! “The most extensive source of patent information available."" Product Portfolio Manager - Dr Reddys Laboratories “The database is reliable, frequently updated, well-arranged, user friendly.” Director IP - Zentiva k.s “Allows me to perform an analysis on an INN in hours rather than days”. IP Council, top 10 generics company Watertight, user-friendly data you can rely on # Key patent, extension and data exclusivity expiry in one simple view # Highly accurate, manually verified data # Full consideration of paediatric, orphan and complex data exclusivity Insight and understanding for all levels of expertise # Patents interpreted and assigned to categories # Expert constraint analysis, commentary, and SPC validity flags # Flags indicate constraining, difficult or nuisance patents # Available on a per molecule basis Save vast amounts of time # Complete, reliable and verifiable data so you don’t have to fill holes and double check # Intelligent, friendly design means fewer clicks and quicker understanding # Hyperlinking to vital patent documentation allows fast analysis and verification # Add your own notes, save searches and results This report covers: International Nonproprietary Name: Abacavir Indications: In combination with other antiretroviral agents, indicated for the treatment of HIV-1 infection. Innovator:GSK (Ziagen, Trizivir, Epzicom, Kivexa) Country Coverage: # Australia # Canada # France # Germany # Great Britain # Italy # Japan # Spain # USA Please note that 51 country coverage is also available. Access: This report is provided through an online portal for a period of 12 months, for a maximum of 5 users. During this period, access to updates, excel exports, patent documents and national registers is provided at no additional charge. About GenericsWeb: Patent, Extension and Data Exclusivity Expiry Snapshot is just one of the benchmark products from Ark Patent Intelligence's product suite from GenericsWeb. Established in 1999, GenericsWeb has customers in over 40 countries including generic and innovator pharmaceutical manufacturers, legal practices, consultants and government departments. Ark Patent Intelligence provides the most comprehensive, relevant and accurate patent information available, stemming from 100% dedication to the industry, extensive experience and investment in customer research and product development.
Table Of Content Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 9 countries (50 country coverage also available), regulatory issues and key players. Examples of information found in this online report include: # Includes key patent publications for 9 main countries # Extension and data exclusivity expiry in one simple view # Expert constraint analysis, commentary, and SPC validity flags # SPC analyser # Full consideration of paediatric,orphan and complex data exclusivity # Patents interpreted and assigned to categories # Summary of dosage forms, strengths, indications and active ingredient forms of the brand product # DMF & Paragraph IV filings # Litigation alerts # Marketing authorisation holders in selected territories # Hyper-linking to crucial patent documents and national registries enabling data verification
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.